IBDEI2O4 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44775,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,44775,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,44776,0)
 ;;=K71.6^^200^2231^32
 ;;^UTILITY(U,$J,358.3,44776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44776,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,44776,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,44776,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,44777,0)
 ;;=K75.9^^200^2231^17
 ;;^UTILITY(U,$J,358.3,44777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44777,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,44777,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,44777,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,44778,0)
 ;;=K71.0^^200^2231^24
 ;;^UTILITY(U,$J,358.3,44778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44778,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,44778,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,44778,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,44779,0)
 ;;=K71.10^^200^2231^30
 ;;^UTILITY(U,$J,358.3,44779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44779,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,44779,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,44779,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,44780,0)
 ;;=K71.11^^200^2231^31
 ;;^UTILITY(U,$J,358.3,44780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44780,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,44780,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,44780,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,44781,0)
 ;;=K71.2^^200^2231^23
 ;;^UTILITY(U,$J,358.3,44781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44781,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,44781,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,44781,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,44782,0)
 ;;=K71.3^^200^2231^28
 ;;^UTILITY(U,$J,358.3,44782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44782,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,44782,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,44782,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,44783,0)
 ;;=K71.4^^200^2231^27
 ;;^UTILITY(U,$J,358.3,44783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44783,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,44783,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,44783,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,44784,0)
 ;;=K75.81^^200^2231^19
 ;;^UTILITY(U,$J,358.3,44784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44784,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,44784,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,44784,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,44785,0)
 ;;=K75.89^^200^2231^16
 ;;^UTILITY(U,$J,358.3,44785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44785,1,3,0)
 ;;=3^Inflammatory Liver Disease,Oth Spec
 ;;^UTILITY(U,$J,358.3,44785,1,4,0)
 ;;=4^K75.89
 ;;^UTILITY(U,$J,358.3,44785,2)
 ;;=^5008829
 ;;^UTILITY(U,$J,358.3,44786,0)
 ;;=K76.4^^200^2231^21
 ;;^UTILITY(U,$J,358.3,44786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44786,1,3,0)
 ;;=3^Peliosis Hepatis
 ;;^UTILITY(U,$J,358.3,44786,1,4,0)
 ;;=4^K76.4
 ;;^UTILITY(U,$J,358.3,44786,2)
 ;;=^91041
 ;;^UTILITY(U,$J,358.3,44787,0)
 ;;=K71.50^^200^2231^25
 ;;^UTILITY(U,$J,358.3,44787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44787,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/o Ascites
 ;;^UTILITY(U,$J,358.3,44787,1,4,0)
 ;;=4^K71.50
 ;;^UTILITY(U,$J,358.3,44787,2)
 ;;=^5008799
 ;;^UTILITY(U,$J,358.3,44788,0)
 ;;=K71.51^^200^2231^26
 ;;^UTILITY(U,$J,358.3,44788,1,0)
 ;;=^358.31IA^4^2
